InnoCare Pharma Limited (HKG:9969)

InnoCare Pharma Revenue

InnoCare Pharma had revenue of 962.05M CNY in the quarter ending September 30, 2026, with 150.60% growth. This brings the company's total for the last twelve months to 3.36B, up 135.36% year-over-year. In the year 2025, InnoCare Pharma had annual revenue of 2.37B with 135.27% growth. That makes InnoCare Pharma the 11,274th largest company in the world by revenue and 679th in Hong Kong.

• Revenue (ttm): 3.36B CNY
• Revenue Growth: +135.36%
• P/S Ratio: 6.57
• Revenue / Employee: 2.42M CNY
• Employees: 1,388
• Market Cap: 25.65B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• China 1.44B 60.6%
• Foreign 935.79M 39.4%

Fiscal year ended Dec 31, 2025 See the full InnoCare Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.37B	1.37B	135.27%
Dec 31, 2024	1.01B	270.91M	36.68%
Dec 31, 2023	738.54M	113.13M	18.09%
Dec 31, 2022	625.40M	-417.63M	-40.04%
Dec 31, 2021	1.04B	1.04B	76,368.70%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error